Hans Wännman

Title: The Innovations of Hans Wännman: A Pioneer in Pharmaceutical Compositions

Introduction

Hans Wännman, an accomplished inventor based in Ängelholm, Sweden, has made significant contributions to the field of pharmaceuticals. With a total of two patents to his name, Wännman has focused his efforts on developing stable pharmaceutical compositions that utilize crystalline salts of quinoline compounds.

Latest Patents

Wännman's latest innovations are encapsulated in his two patents. The first relates to crystalline salts of quinoline compounds and methods for preparing them. This patent describes a stable solid pharmaceutical composition that includes an effective amount of a crystalline salt, specifically formulated to remain stable during storage at room temperature for at least three years. It also outlines a method for stabilizing these compounds. The second patent involves compositions containing quinoline compounds, which include a similar stable solid pharmaceutical composition, further demonstrating Wännman's expertise in creating reliable pharmaceutical formulations.

Career Highlights

Hans Wännman has been an integral part of Active Biotech AB, where he has applied his innovative thinking to advance pharmaceutical research. His ability to develop novel formulations has positioned him as a key figure in his company, contributing to its growth in the industry.

Collaborations

Throughout his career, Wännman has worked closely with colleagues Karl Erik Jansson and Tomas Fristedt. Together, they have collaborated on various projects, pooling their expertise to enhance the development of pharmaceutical solutions and achieve remarkable results.

Conclusion

Hans Wännman's innovative work in the realm of pharmaceutical compositions exemplifies his dedication to improving the stability and efficacy of medications. His contributions have not only furthered scientific knowledge but also have the potential to benefit patients worldwide through enhanced drug formulations.